Eosinophilic Asthma Secondary to Adjuvant Anti-PD-1 Immune Checkpoint Inhibitor Treatment in a Melanoma Patient

BACKGROUND: Adjuvant immune checkpoint inhibitors are a new standard of care in melanoma. However, the immune related toxicity associated with these agents can be serious, and the long-term implications are yet to be defined especially in the adjuvant setting. We report, to our knowledge, the first...

Descripción completa

Detalles Bibliográficos
Autores principales: Kissoonsingh, P., Sutton, B., Iqbal, Syed U., Pallan, Lalit, Steven, Neil, Khoja, L.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Hindawi 2022
Materias:
Case Report
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9078828/
https://www.ncbi.nlm.nih.gov/pubmed/35535354
http://dx.doi.org/10.1155/2022/2658136

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9078828/
https://www.ncbi.nlm.nih.gov/pubmed/35535354
http://dx.doi.org/10.1155/2022/2658136

Ejemplares similares